注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig)   

Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig)

     
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig)on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    The purity of Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig)is 94.61%, determined by SEC-HPLC.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    Tobemstomig bound to LAG-3 protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Tobemstomig bound human LAG-3 Protein-His, and the EC50 was 0.2401 nM.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    Tobemstomig bound to PD-1 protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Tobemstomig bound human PD-1 Protein-His, and the EC50 was 0.02504 nM.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    Tobemstomig bound to huPD-1-Jurkat cells, and then rebounded to fluorescent secondary antibodies(Anti-Human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Tobemstomig bound to huPD-1-Jurkat cells, and the EC50 was 1.222 nM.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    Tebotelimab bound to huLAG-3-CHO-K cells, and then rebounded to fluorescent secondary antibodies(Anti-Human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Tebotelimab bound to huLAG-3-CHO-K cells, and the EC50 was 8.727 nM.
  • 0 - Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) APR11595
    The detected weight of Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig) is 145.01 kDa.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P18627 & Q15116
Reactivity Human
Clonality Bispecific
Isotype IgG-like
Additional Information
Target/Specificity PDCD1 / PD-1 / CD279,LAG3 / CD223
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价